LIDOCAINE HCI inj 2%

Lidocaine HCI Inj 2% is a versatile local anesthetic and antiarrhythmic agent widely used in medical settings. Known for its fast-acting anesthetic properties, it is ideal for numbing specific areas during surgical or diagnostic procedures, minimizing patient discomfort. Additionally, Lidocaine HCI Inj 2% is effective in managing cardiac arrhythmias, particularly for patients experiencing conditions such as ventricular tachycardia and ventricular extrasystoles, stabilizing heart rhythms and preventing further complications.

Lidocaine’s flexibility in administration, from intravenous to intramuscular or subcutaneous routes, makes it adaptable to various clinical needs. It is designed for use by healthcare professionals, ensuring safety and effectiveness in procedures requiring localized anesthesia or cardiac rhythm management.

Key Benefits of Lidocaine HCI Inj 2%

1. Quick Anesthesia: Provides rapid local anesthesia, which is essential for reducing patient discomfort during minor surgical or diagnostic procedures.
2. Cardiac Arrhythmia Management: Effectively controls ventricular tachycardia and extrasystoles, stabilizing heart rhythms for patients with severe arrhythmic conditions.
3. Flexible Administration Routes: Can be administered intravenously, intramuscularly, or subcutaneously, accommodating a wide range of clinical situations and patient needs.

Recommended Dosage and Administration

Lidocaine HCI Inj 2% should be administered by trained healthcare professionals with precise dosing to ensure optimal patient outcomes. The recommended dosage may vary based on the patient’s condition, age, and weight.

1. For Adults:
   • Initial Dose: Administer slowly over 1–2 minutes, typically at a dose of 50–100 mg (1–2 mg/kg).
   • Repeated Doses: If necessary, repeat a similar dose after five minutes. Additional doses may be administered at intervals of 10–20 minutes, with a maximum of 300 mg per hour.
   • Continuous Infusion: For extended anesthesia or arrhythmia management, a continuous IV infusion can be administered at 1–2 mg per minute, increasing up to 4 mg per minute as required, under ECG monitoring to ensure heart stability.

Packaging and Dosage Form

Lidocaine HCI Inj 2% is conveniently packaged for clinical use, ensuring precise dosing and ease of handling in medical environments:

• Packaging: Each package contains 10 vials, with each vial holding 20 ml of Lidocaine HCI 2%, suitable for multiple doses or continuous infusion as needed.

Storage Recommendations

To maintain its efficacy, Lidocaine HCI Inj 2% should be stored under the following conditions:

• Temperature: Store at temperatures not exceeding 30°C, protecting the product from temperature extremes that could affect stability.
• Shelf Life: Use within the designated shelf life to ensure safety and effectiveness.

Usage Note

Lidocaine HCI Inj 2% is intended for use by healthcare professionals skilled in administering local anesthetics and managing cardiac arrhythmias. Dosage adjustments may be necessary based on factors such as patient age, weight, and overall health condition, ensuring individualized care for safety and efficacy.

Patients should be monitored closely, particularly during intravenous administration for arrhythmia management, with ECG monitoring to observe cardiac response and adjust the dosage as needed.

Who Should Use Lidocaine HCI Inj 2%?

Lidocaine HCI Inj 2% is suitable for use in:

• Surgical and Diagnostic Procedures: Providing rapid local anesthesia to minimize discomfort during minor surgeries or diagnostic tests.
• Cardiac Arrhythmia Management: Stabilizing heart rhythms in patients with serious conditions like ventricular tachycardia or extrasystoles.

With its adaptable dosing and rapid action, Lidocaine HCI Inj 2% is a reliable choice for healthcare providers seeking an effective anesthetic and arrhythmia management solution in a clinical setting.